|     home    |     search     |     content     |     mail     |     login     |
studies of CLB (120) which were not included in the Bolder project

with reason for exclusion.

211773801-10-2001T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock.
reason:
211354751-3-2001High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function.
reason:
205680011-11-2000The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation.
reason:
204908141-10-2000Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.
reason:
203921211-9-2000Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term In vivo or In vitro passage through chimpanzees.
reason:monkeys
204295321-9-2000Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection.
reason:
203750351-8-2000Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans.
reason:geen cohort
202989331-6-2000High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission.
reason:
202663769-5-2000Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy.
reason:
201737111-4-2000Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice.
reason:
2017925818-2-2000Normalization of the CD4 T cell receptor repertoire after evolution of syncytium-inducing HIV-1 variants.
reason:
200762641-1-2000T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).
reason:niet in cohort
200270321-12-1999Treatment with granulocyte colony-stimulating factor decreases the capacity of hematopoietic progenitor cells for generation of lymphocytes in human immunodeficiency virus-infected persons.
reason:niet in cohort
200515251-11-1999Supportive use of amifostine in patients with head and neck tumors undergoing radio-chemotherapy. Is it possible to limit the duration of the application of amifostine?
reason:niet in cohort
993702271-9-1999R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus.
reason:not a cohort study
993153051-7-1999Evidence that human CD8+CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division.
reason:niet in cohort
992842637-5-1999Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study).
reason:niet in cohort
992419671-4-1999Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients.
reason:niet in cohort
992094961-3-1999Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts.
reason:niet in cohort
992174764-2-1999Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.
reason:niet in cohort

displaying records 1 to 20 of 120


  • click on a studycode to view more details
  • click on "all studies" to view a list of all studies for this institute
  • click on "included studies" to view a list of all studies for this institute that were included in the Bolder project.
  • if not all records are displayed, click on 'display all records' to view them all
  • click on the back button to go to the previous screen